— Know what they know.
Not Investment Advice

HMPQ OTC

HempAmericana, Inc
1W: +0.0% 1M: -99.0% 3M: +0.0% YTD: -99.0% 1Y: +0.0% 3Y: -99.5% 5Y: -99.9%
$0.00
+0.00 (+0.00%)
 
Weekly Expected Move ±9867.9%
$-0 $-0 $0 $0 $0
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 49 · $291753 mcap · 2.76B float · 0.0063% daily turnover

Balance Sheet Trends

Total Assets
$2M -11.0% ▼
5Y CAGR: +190.4%
Total Liabilities
$4M +0.9% ▲
5Y CAGR: +496.6%
Shareholders Equity
-$1M -38.2% ▼
Cash & Investments
$3K +23.2% ▲
5Y CAGR: +30.7%
Total Debt
$23K +1253.3% ▲
Net Debt
$20K +2504.6% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2016FY2017FY2018FY2019FY2020
— Assets —
Cash$383$202K$80K$3K$3K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$383$202K$80K$3K$3K
Net Receivables$0$247K$229K$234K$0
Inventory$12K$12K$333K$278K$292K
Other Current Assets$200K$286K$10K$70K$70K
Total Current Assets$213K$747K$652K$584K$364K
Property, Plant & Equip.$0$850K$2M$2M$2M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$0$850K$2M$2M$2M
Total Assets$213K$2M$3M$3M$2M
— Liabilities —
Accounts Payable$1K$480$1K$8K$8K
Short-Term Debt$384K$202K$2K$2K$23K
Deferred Revenue-$0$0$0$0$0
Other Current Liabilities$0$0$3K$3K$16K
Total Current Liabilities$386K$3M$3M$4M$4M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$0$0$0$0$0
Total Liabilities$386K$3M$3M$4M$4M
— Equity —
Common Stock$131K$0$0$0-$1M
Retained Earnings-$505K-$3M-$4M-$5M-$6M
Accumulated OCI$332K$0$0$0$5M
Total Stockholders Equity-$173K-$2M-$430K-$873K-$1M
Total Liabilities & Equity$213K$2M$3M$3M$2M
— Key Metrics —
Total Debt$384K$202K$2K$2K$23K
Net Debt$384K$80-$78K-$819$20K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms